“…Not Intended to Diagnose, Treat, Cure or Prevent Any Disease.” 25 Years of Botanical Dietary Supplement Research and the Lessons Learned
Authors:
- 13 July 2018
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 104 (3) , 470-483
Abstract
Botanical dietary supplements (BDS) are complex mixtures of phytochemicals exhibiting complex pharmacology and posing complex research challenges. For 25 years, clinical pharmacologists researching BDS have confronted a litany of issues unlike those encountered with conventional medications. Foundational to these concerns is the Dietary Supplement Health and Education Act of 1994, which exempted BDS from premarket safety and efficacy trials. In the ensuing period, safety concerns regarding multi‐ingredient products formulated as “proprietary blends” and herb‐drug interactions have garnered significant attention. Idiosyncrasies unique to BDS can affect the outcome and interpretation of in vitro and in vivo studies, and although “omics” approaches hold promise in uncovering BDS efficacy mechanisms, purposeful adulteration threatens their safety. Despite a quarter century of public use, healthcare professionals still know little about BDS, thus it falls to industry, government, and academia to join forces in promoting a new paradigm for BDS research and product development.Keywords
This publication has 76 references indexed in Scilit:
- Influence of a Polyphenol-Enriched Protein Powder on Exercise-Induced Inflammation and Oxidative Stress in Athletes: A Randomized Trial Using a Metabolomics ApproachPLOS ONE, 2013
- Limitations of In Vitro Assessments of the Drug Interaction Potential of Botanical SupplementsPlanta Medica, 2012
- Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical RelevancePlanta Medica, 2012
- Pharmacokinetic Herb-Drug Interactions (Part 1): Origins, Mechanisms, and the Impact of Botanical Dietary SupplementsPlanta Medica, 2012
- The effect of grapefruit juice on drug dispositionExpert Opinion on Drug Metabolism & Toxicology, 2011
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer StudyCancer Prevention Research, 2010
- Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicityDrug Metabolism Reviews, 2010
- Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United StatesJAMA, 2008
- Predicting interactions between conventional medications and botanical products on the basis ofin vitroinvestigationsMolecular Nutrition & Food Research, 2008
- In vitro and in vivo assessment of herb drug interactionsLife Sciences, 2006